Title:
CEFMENOXIME HYDROCHLORIDE NEW CRYSTALLINE FORM AND FORMULATION
Document Type and Number:
WIPO Patent Application WO/2017/140074
Kind Code:
A1
Abstract:
Disclosed are a cefmenoxime hydrochloride new crystalline compound and crystallization preparation method thereof; said cefmenoxime hydrochloride new crystalline compound is formed using particle processing for molecular assembly and morphological optimization of a crystalline product. The present compound has the features of high purity, good fluidity, and good stability. Also disclosed is a formulation -- cefmenoxime hydrochloride used for injection -- fabricated using the described cefmenoxime hydrochloride compound.
More Like This:
Inventors:
TAO LINGGANG (CN)
WANG JINGKANG (CN)
YIN QIUXIANG (CN)
HAO HONGXUN (CN)
WANG JINGKANG (CN)
YIN QIUXIANG (CN)
HAO HONGXUN (CN)
Application Number:
PCT/CN2016/085307
Publication Date:
August 24, 2017
Filing Date:
June 08, 2016
Export Citation:
Assignee:
HAINAN LINGKANG PHARMACEUTICAL (CN)
UNIV TIANJIN (CN)
TAO LINGGANG (CN)
WANG JINGKANG (CN)
YIN QIUXIANG (CN)
HAO HONGXUN (CN)
UNIV TIANJIN (CN)
TAO LINGGANG (CN)
WANG JINGKANG (CN)
YIN QIUXIANG (CN)
HAO HONGXUN (CN)
International Classes:
C07D501/36; A61K31/546; A61P31/04; C07D501/06; C07D501/12
Foreign References:
CN101735249A | 2010-06-16 | |||
CN103159786A | 2013-06-19 | |||
CN102603772A | 2012-07-25 | |||
CN103554136A | 2014-02-05 | |||
CN105001239A | 2015-10-28 | |||
CN105566352A | 2016-05-11 |
Attorney, Agent or Firm:
BEIJING CONCEPT INTELLECTUAL PROPERTY AGENCY (CN)
Download PDF: